These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12509641)

  • 21. [Can a combination therapy with leflunomide be recommended for patients with active rheumatoid arthritis?].
    Hamann F
    Z Rheumatol; 2003 Apr; 62(2):204-5. PubMed ID: 12820624
    [No Abstract]   [Full Text] [Related]  

  • 22. [Efficacy and safety of treatment with methotrexate, leflunomide, detralex, and their combination of patients with rheumatoid arthritis].
    Shevchuk SV; Stanislavchuk MA; Pentiuk OO
    Lik Sprava; 2003; (3-4):34-41. PubMed ID: 12889354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lefunomide in combination therapy.
    Kalden JR; Smolen JS; Emery P; van Riel PL; Dougados M; Strand CV; Breedveld FC
    J Rheumatol Suppl; 2004 Jun; 71():25-30. PubMed ID: 15170905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe hepatotoxicity in a rheumatoid arthritis patient switched from leflunomide to methotrexate.
    Gupta R; Gupta SK
    MedGenMed; 2005 Sep; 7(3):9. PubMed ID: 16369235
    [No Abstract]   [Full Text] [Related]  

  • 25. [2 years data of controlled trials with leflunomide vs. methotrexate and leflunomide vs. sulfasalazine].
    Krüger K
    Z Rheumatol; 2002 Jun; 61(3):308-10. PubMed ID: 12219638
    [No Abstract]   [Full Text] [Related]  

  • 26. [Leflunomide in combination with TNF-blockers for Methotrexate intolerance].
    Krüger K; Manger B;
    Z Rheumatol; 2009 Mar; 68(2):165-8. PubMed ID: 19159938
    [No Abstract]   [Full Text] [Related]  

  • 27. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
    Behrens F; Koehm M; Burkhardt H
    Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymyositis associated with infliximab treatment for rheumatoid arthritis.
    Urata Y; Wakai Y; Kowatari K; Nitobe T; Mizushima Y
    Mod Rheumatol; 2006; 16(6):410-1. PubMed ID: 17165006
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis.
    Popovic M; Stefanovic D; Pejnovic N; Popovic R; Glisic B; Obradovic S; Dimitrijevic M
    Transplant Proc; 1998 Dec; 30(8):4135-6. PubMed ID: 9865325
    [No Abstract]   [Full Text] [Related]  

  • 30. Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis.
    Henes JC; Schedel J; Kanz L; Koetter I
    Rheumatol Int; 2010 Mar; 30(5):709-12. PubMed ID: 20012622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice.
    Perdriger A; Mariette X; Kuntz JL; Brocq O; Kara-Terki R; Loet XL; Cantagrel A; Pavy S; Deslandre CJ; Debiais F; Combe B;
    J Rheumatol; 2006 May; 33(5):865-9. PubMed ID: 16652418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and safety of infliximab combined with leflunomide in chronic polyarthritis.
    Ortiz García AM; González-Alvaro I; Roselló Pardo R; Carmona L; Fábregas Canales MD; Monteagudo Saez I;
    Clin Exp Rheumatol; 2004; 22(6):790. PubMed ID: 15638063
    [No Abstract]   [Full Text] [Related]  

  • 33. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
    D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
    Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis.
    Hansen KE; Cush J; Singhal A; Cooley DA; Cohen S; Patel SR; Genovese M; Sundaramurthy S; Schiff M
    Arthritis Rheum; 2004 Apr; 51(2):228-32. PubMed ID: 15077264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extraarticular rheumatoid arthritis and drug-induced syndromes: understanding the role of tumor necrosis factor inhibitors.
    Bruyn GA
    J Rheumatol; 2004 Jul; 31(7):1461; author reply 1462. PubMed ID: 15229972
    [No Abstract]   [Full Text] [Related]  

  • 36. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
    Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN;
    N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate.
    McEwen J; Purcell PM; Hill RL; Calcino LJ; Riley CG
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):65-73. PubMed ID: 16634119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab.
    Allanore Y; Sellam J; Batteux F; Job Deslandre C; Weill B; Kahan A
    Clin Exp Rheumatol; 2004; 22(6):756-8. PubMed ID: 15638051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination.
    Toth P; Bernd R
    Rev Bras Reumatol; 2014; 54(2):152-4. PubMed ID: 24878863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.